United Therapeutics Corporation
Martine A Rothblatt (Chairperson & CEO) sells UTHR shares
AI-generated summary
Chairperson & CEO, Director Martine A Rothblatt exercised options for 9,500 shares at an average price of $117.76 valued at $1,118,720 and sold 9,500 shares at an average price of $580.43 valued at $5,514,046 indirectly by Trust. After these transactions, the insider held 324,443 shares indirectly by Trust. The transactions were made under a Rule 10b5-1 trading plan adopted on November 7, 2025.
Key facts
- Insider
- Martine A Rothblatt · Chairperson & CEO, Director
Rule 10b5-1 plan · adopted Nov 7, 2025
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +9,500 | $117.76 | $1,118,720.00 | 333,943 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F3, F2 | −373 | $576.16 | $214,908.65 | 333,570 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F4, F2 | −1,017 | $577.14 | $586,949.55 | 332,553 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F5, F2 | −1,763 | $578.17 | $1,019,318.65 | 330,790 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F6, F2 | −1,127 | $579.11 | $652,655.39 | 329,663 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F7, F2 | −955 | $580.13 | $554,025.68 | 328,708 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F8, F2 | −1,112 | $581.18 | $646,269.60 | 327,596 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F9, F2 | −449 | $582.57 | $261,575.77 | 327,147 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F10, F2 | −2,004 | $583.22 | $1,168,763.46 | 325,143 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F11, F2 | −381 | $584.22 | $222,586.41 | 324,762 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F12, F2 | −79 | $585.27 | $46,236.39 | 324,683 | Indirect (by Trust) |
| Nov 17, 2026 | S · open-market saleFootnotes F1, F13, F2 | −240 | $586.49 | $140,756.50 | 324,443 | Indirect (by Trust) |
| Nov 17, 2026 | M · exercise or conversion of a derivativeStock OptionFootnotes F1, F17, F18 | −9,500 | $0.00 | $0.00 | 5,410 | Indirect (by Trust) |
Footnotes
- F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10 This transaction was executed in multiple trades at prices ranging from $582.86 to $583.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11 This transaction was executed in multiple trades at prices ranging from $583.86 to $584.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12 This transaction was executed in multiple trades at prices ranging from $585.01 to $585.525. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13 This transaction was executed in multiple trades at prices ranging from $586.48 to $586.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F15 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F16 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17 These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F18 Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3 This transaction was executed in multiple trades at prices ranging from $575.68 to $576.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $576.68 to $577.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $577.68 to $578.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $578.68 to $579.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $579.70 to $580.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8 This transaction was executed in multiple trades at prices ranging from $580.72 to $581.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9 This transaction was executed in multiple trades at prices ranging from $581.84 to $582.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More UTHR filings
- 4
Filed Nov 19, 2026
- 4
Filed Nov 19, 2026
- 144
Filed Nov 19, 2026
- 4
Filed Nov 17, 2026
- 4
Filed Nov 16, 2026
- 4
Filed Nov 13, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.